European Cancer Resolution will benefit patients and all those who treat and car... ( An initiative to combat cancer in th...)

European Cancer Resolution will benefit patients and all those who treat and care for them

Date:4/10/2008

An initiative to combat cancer in the enlarged European Union has been adopted in a plenary session of the European Parliament today (Thursday 10 April). The adoption of the Cancer Resolution has been welcomed by ECCO the European CanCer Organisation which says that patients, and all those who care for them, will benefit if the European Commission and Member States take action on the Resolution's 40 proposals.

ECCO particularly welcomes the proposal that the Commission should revise the Clinical Trials Directive to encourage more academic research on cancer.

Professor Alexander M.M. Eggermont, the President of ECCO, said: We are particularly concerned about the impact of the Clinical Trials Directive, in its present form, on the conduct of clinical trials of cancer treatments. While well intentioned and designed to protect patients interests, we believe that it may well be having the opposite effect. It has set so many regulations in place that the cost of trials has doubled or quadrupled, making it difficult for trials to be run without funding from industry. As a consequence, the number of academically-funded trials is declining, which is bad news for any patients with rare cancers, for patients living in under-resourced countries, and for practitioners who are trying to find better combinations of existing therapies that will be more effective in treating the disease.

This is a serious and undesired effect of the Directive as it threatens academic independence and innovative cancer research and is contrary to the best interests of patients.

Other proposals in the Cancer Resolution include:

encouraging the establishment of multi-disciplinary oncology teams in Member States in order to improve treatments for patients and education for all healthcare professionals so that they recognise the psychosocial needs of patients;

calling on the Commission to ensure there is adequate funding for co-ordinate
'/>"/>

Contact: Emma Mason
wordmason@mac.com
07-711-296-986
ECCO-the European CanCer Organisation
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. New pan-European collaboration launched into the diagnosis and control of coeliac disease
2. European Society for Medical Oncology and European CanCer Organization join forces
3. FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
4. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
5. IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management
6. More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
7. Gene expression differences between Europeans and Africans affect response to drugs, infections
8. Space sentinels: New tools in space to improve European environment and security policies
9. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
10. Specialty European Pharma launches plenaxis in Germany
11. DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor

Post Your Comments:

(Date:3/21/2010)... President Tony Perkins released the following statement in response to reports that President Obama may issue an executive order regarding government funding of ... ... , ... ... ...

(Date:3/18/2010)... ... your Mom , ... 18, 2010 -- This Mother’s Day, Save the Children has a special gift for your ... the world. For as little as $13 you can buy, in your own mother’s name, ...

(Date:3/18/2010)... ... ... ... March 18 Kids in Minnesota will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide for ...

(Date:3/18/2010)... ... ... ... WASHINGTON , March 18 Kids in New Hampshire will take center stage in the fight against tobacco on March 24 as they join ...

(Date:3/18/2010)... State Leaders Urged to Support Higher Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 ...

[0] Executive Order Will In No Way Prevent Federal Funding of Elective Abortion [0] A Mother's Day Gift that Gives Lasting Joy [0] Minnesota Kids 'Kick Butts' on March 24 [0] New Hampshire Kids 'Kick Butts' on March 24 [0] Montana Kids 'Kick Butts' on March 24

... CUISINE IN ... to host the event and Sopranos star and winemaker Lorraine ... to showcase Bracco Wines Michael Schulson star of Style Network,s "Pantry Raid" and Geoffrey, ... head-to-head in a ...

... located in the main concourse area, GREEN, Ohio, Oct. ... your flu shot the next time you fly out of ... Akron, to provide you with another way to get your ... shots (recommended for the elderly and,those who have had pneumonia) ...

... Alliance --, WESTPORT, Conn., Oct. 18 Rite ... Diabetes Alliance with dLife, the only,integrated multimedia education platform ... estimated 20.8 million(1) people in the United States,currently living ... The goal of the 360 degrees/365 Program is to ...

... YMCAs Get Their Communities Moving During Week-Long Event; ... Aim to Keep Communities Active Year-Round, WASHINGTON, Oct. 18 ... "America On the Move Week with the YMCA" to,inspire a ... than 1,500 YMCAs nationwide reached out to their communities to,promote ...

... physician, experts say , THURSDAY, Oct. 18 (HealthDay News) ... known, but potentially serious, symptoms of gastroesophageal reflux disease ... don,t realize they have GERD, the researchers noted in ... meeting of the American College of Gastroenterology, in Philadelphia. ...

... Enact HR 1174 (Murphy) to Spur,Hospitals to Reduce ... A new study that,estimates nearly 19,000 Americans died ... in the hospital underscores,the need for Congress to ... Consumers Union, the nonprofit publisher of Consumer,Reports., ...

Other Medicine News:Health News:Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event 2 Health News:Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event 3 Health News:Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event 4 Health News:Akron-Canton Airport offering flu shot clinic for 90 days 2 Health News:Rite Aid and dLife Partner to Educate and Support Diabetes Community 2 Health News:Rite Aid and dLife Partner to Educate and Support Diabetes Community 3 Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 2 Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 3 Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 4 Health News:Reflux Can Precipitate Chest Pain, Cough 2 Health News:Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections 2 Health News:Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections 3

Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event Akron-Canton Airport offering flu shot clinic for 90 days Rite Aid and dLife Partner to Educate and Support Diabetes Community YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA'Reflux Can Precipitate Chest Pain, Cough Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections

(Date:3/18/2010)... HARBIN, China , March 18 ... One Medical" or "the Company") (Nasdaq: CSKI ... in the People,s Republic of China ... anti-cancer drug co-developed by Taiwan,Golden Biotechnology Corporation ("Golden ...

(Date:3/17/2010)... March 17 Kendle (Nasdaq: KNDL ), a leading, ... , Vice President, Asia/Pacific will address the World Pharma ... at the Raffles City Convention Centre in Singapore . Dr. ... scheduled for March 18 at 2 p.m. ...

(Date:3/17/2010)... ... ... ... SILVER SPRING, Md. , March 17 The U.S. Food and Drug Administration today announced the approval of the Esteem – an implanted hearing system used to treat moderate ...

[0] China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology [0] Kendle Executive to Share Insights at World Pharma Trials Asia 2010 [0] FDA Approves First Totally Implanted Hearing System

... Shows Survival Benefit in Complete and ... with Chemotherapy Alone, BERKELEY HEIGHTS, N.J., May 29 ... of long-term,followup from a Phase 3 trial of the ... with chronic,lymphocytic leukemia (CLL). With 5 years of followup, ...

... for Patients with,Chemotherapy-Induced Nausea and Vomiting, ... today announced the submission of a new ... Administration and new data from two,Phase III ... receptor antagonist. The data demonstrated a,significant and ...

Other Medicine Technology:Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 2 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 3 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 4 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 5 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 6 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 7 GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 8

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

The BX41 offers an outstanding range of features and optical performance for the clinical market. With an emphasis on high-quality optics and a rigid frame, the BX41 offers improved versatility and e...

The TS100-F trinocular model comes with a photo port that accepts Nikon's FX-III series photomicrographic systems, CCTV camera, or digital camera....

... standard laboratory microscope whose superior ... combine to make it the ... is designed to fit the ... user to fit the microscope. ...

... charts incorporate the slight change in the ... Sloan letters derived from the best corrected ... the ETDRS study. The original charts difficulty ... 234 eyes. In addition to the revised ...

Medicine Products:

BX41 Microscope Eclipse TS100F Eclipse E400 Reduced 2000 series revised ETDRS Translucent Charts

European Cancer Resolution will benefit patients and all those who treat and car...( An initiative to combat cancer in th...),Health